108 related articles for article (PubMed ID: 3681426)
21. Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles.
Han L; Ren Y; Long L; Zhong Y; Shen C; Pu P; Yuan X; Kang C
Oncol Rep; 2012 Jan; 27(1):121-8. PubMed ID: 21922149
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary report.
Decker DA; Al Sarraf M; Kresge C; Austin D; Wilner HI
J Neurooncol; 1985; 3(1):19-21. PubMed ID: 2987424
[TBL] [Abstract][Full Text] [Related]
23. Effect of alpha-difluoromethylornithine on 1,3-bis(2-chloroethyl)-1-nitrosourea and cis-diamminedichloroplatinum(II) cytotoxicity, DNA interstrand cross-linking, and growth in human brain tumor cell lines in vitro.
Hunter KJ; Deen DF; Pellarin M; Marton LJ
Cancer Res; 1990 May; 50(9):2769-72. PubMed ID: 2109657
[TBL] [Abstract][Full Text] [Related]
24. Application of in vivo and in vitro pharmacokinetics for physiologically relevant drug exposure in a human tumor clonogenic cell assay.
Ali-Osman F; Giblin J; Dougherty D; Rosenblum ML
Cancer Res; 1987 Jul; 47(14):3718-24. PubMed ID: 2954633
[TBL] [Abstract][Full Text] [Related]
25. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
Zhang RX; Dougherty DV; Rosenblum ML
Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of spirohydantoin mustard for the treatment of recurrent malignant gliomas.
Prados M; Rodriguez L; Seager M; Silver P; Levin V
Cancer Treat Rep; 1987 Nov; 71(11):1105-6. PubMed ID: 3119204
[No Abstract] [Full Text] [Related]
27. Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomas.
Curt GA; Kelley JA; Kufta CV; Smith BH; Kornblith PL; Young RC; Collins JM
Cancer Res; 1983 Dec; 43(12 Pt 1):6102-5. PubMed ID: 6640549
[TBL] [Abstract][Full Text] [Related]
28. Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug.
Wallner KE; DeGregorio MW; Li GC
Cancer Res; 1986 Dec; 46(12 Pt 1):6242-5. PubMed ID: 3779644
[TBL] [Abstract][Full Text] [Related]
29. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats.
Emerich DF; Winn SR; Bartus RT
Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219
[TBL] [Abstract][Full Text] [Related]
30. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
[TBL] [Abstract][Full Text] [Related]
31. Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells.
Horvath Z; Bauer W; Hoechtl T; Saiko P; Fritzer-Szekeres M; Tihan T; Szekeres T
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1531-5. PubMed ID: 15571292
[TBL] [Abstract][Full Text] [Related]
32. Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council.
Haid M; Khandekar JD; Christ M; Johnson CM; Miller SJ; Locker GY; Merrill JM; Reisel H; Hatfield A; Lanzotti V
Cancer; 1985 Sep; 56(6):1311-5. PubMed ID: 4027870
[TBL] [Abstract][Full Text] [Related]
33. Preliminary communication--treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ;NSC-182986).
Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD
Am J Clin Oncol; 1983 Oct; 6(5):577-8. PubMed ID: 6613923
[TBL] [Abstract][Full Text] [Related]
34. Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.
Kapp J; Vance R; Parker JL; Smith RR
Neurosurgery; 1982 Jun; 10(6 Pt 1):715-9. PubMed ID: 7110545
[No Abstract] [Full Text] [Related]
35. Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations.
Schold SC; Friedman HS; Bjornsson TD; Bigner DD
Cancer Res; 1984 Jun; 44(6):2352-7. PubMed ID: 6722774
[TBL] [Abstract][Full Text] [Related]
36. Timing of combined hyperthermia and 1,3-bis(2-chloroethyl)-1-nitrosourea or cis-diamminedichloroplatinum in BD IX rats with BT4A tumours.
Mella O; Dahl O
Anticancer Res; 1985; 5(3):259-63. PubMed ID: 4040349
[TBL] [Abstract][Full Text] [Related]
37. Aziridinylbenzoquinone (AZQ) in the treatment of recurrent pediatric brain and other malignant solid tumors. A Pediatric Oncology Group phase II study.
Castleberry RP; Ragab AH; Steuber CP; Kamen B; Toledano S; Starling K; Norris D; Burger P; Krischer JP
Invest New Drugs; 1990 Nov; 8(4):401-6. PubMed ID: 2084075
[TBL] [Abstract][Full Text] [Related]
38. DNA cross-linking responses of human malignant glioma cell strains to chloroethylnitrosoureas, cisplatin, and diaziquone.
Sariban E; Kohn KW; Zlotogorski C; Laurent G; D'Incalci M; Day R; Smith BH; Kornblith PL; Erickson LC
Cancer Res; 1987 Aug; 47(15):3988-94. PubMed ID: 3038305
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanoma.
Creagan ET; Schutt AJ; Ahmann DL; Green SJ
Cancer Treat Rep; 1982 Dec; 66(12):2089-90. PubMed ID: 7139650
[TBL] [Abstract][Full Text] [Related]
40. Chemosensitivity testing for human brain tumors.
Rosenblum ML
Prog Clin Biol Res; 1980; 48():259-76. PubMed ID: 7208520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]